A yellow-orange substance present in human blood is called bilirubin. This natural coloring is secreted by our liver. It is discharged in the bile and is formed from the breakdown of hemoglobin. From the blood, it reaches the liver and is stored there. Bilirubin is removed from the body through the excretory ducts. The condition of high bilirubin level is common in babies. It gives rise to yellowing of the skin and eyes. A bilirubin blood test is done to check the level of yellow bilirubin in the blood. When the liver is functioning properly, it expels all of the bilirubin from the body. If the level of bilirubin is high, it drains from the liver and causes diseases such as jaundice, dark urine and others. A high bilirubin blood test allows us to monitor the bilirubin count in the blood by detecting problems related to the gallbladder. Bilirubin Blood Test market size is calculated to index a CAGR of 5.44%. Its market value is estimated to rise to US$1,853.2 million by the year 2027. covid19 analysis Due to the spread of the infectious coronavirus, people face various respiratory problems. Many patients have reported elevated levels of bilirubin in blood tests, which is a serious concern. Although the death rate due to increased bilirubin level is not high. Government and medical agencies are investing in Research and Development programs. It will facilitate quick diagnosis. Low Bilirubin Blood Test and High Bilirubin Blood Test include complicated process of sample collection, fluid handling, device packaging, etc. Therefore, the need arises to develop more effective ways of performing the bilirubin blood test with minimal compromise. market dynamics drivers Illnesses like jaundice, dark urine and gallbladder related problems are increasing rapidly. This is leading to an increase in demand for bilirubin blood test devices. Boys or newborn babies are more prone to these problems because the liver does not absorb bilirubin properly soon after birth. This has fueled market demand for easy-to-use, portable test kits. Therefore, the market size of Bilirubin Blood Test is expected to grow rapidly during the forecast period. Opportunities The growth of the bilirubin blood test market can be attributed to constant changes in technology. The need to develop new devices and test techniques is increasing in order to obtain more accurate and reliable results. Easy-to-use, downloadable test kits are being developed for this purpose. People are becoming aware and adapting to a healthy lifestyle. The government of each nation is also investing its resources in health camps where large numbers of people are treated. This increased the percentage of bilirubin blood tests. restrictions Certain other types of testing techniques that are being used by individuals or agencies other than pathology laboratories or research institutes pose a real threat to the market size of bilirubin blood tests. Testing by non-pathologists is unreliable and may give false results. Value chain analysis Major players in the Bilirubin Blood Test market are making technological advancements. They are coming out with such instruments that will require a minimum amount of blood to test a patient's blood bilirubin level. As cases of jaundice are more frequent in babies and newborns, companies are developing techniques that will be less painful and will not harm them. Market segmentation The bilirubin blood test market can be divided into several segments. They are: depending on the type of test, depending on the type of product, depending on the application and depending on the end users.Bilirubin Blood Test Market Analysis:
Based on test type
The various types of tests performed on the bilirubin blood test market are as follows: total serum bilirubin (TSB); Direct/conjugated bilirubin test; Indirect/unconjugated bilirubin test
Based on product type
Based on the product type, the bilirubin blood test market is divided into two types, namely consumables and instruments. Consumables are not reusable materials. Consumables alone accounted for a market share of 47.37% in 2015, the highest among all other segments. Instruments can be further classified into bilirubin analyzers and bilirubin meters.
based on app
The market is divided into infants or newborns and adults. The chances of jaundice in pediatrics are higher than in adults, therefore, babies constitute the largest percentage of consumers in the bilirubin blood test market.
Based on end users
Bilirubin blood test is performed in diagnostic centers, pathological laboratories and hospitals. Research laboratories and other academic institutions also contribute a lot to the market. Pediatric clinics and children's hospitals are also end users.
Regional Analysis
The market size of bilirubin blood tests is increasing with each passing day. It is leaving its mark in every corner of the world. The regions they operate in include North America, Europe, Asia Pacific and the rest of the world.
North America, which includes the US and Canada area, is outperforming all other regions. It was responsible for a share of 39.10% in the year 2014, being the largest in the global market for bilirubin blood tests. US market share is expected to reach a CAGR of 4.93%.
The European region, which includes Germany, UK, France, Russia and Italy, has captured the position of second largest market share in the blood bilirubin testing market. Germany is presumed to touch the highest figure, with USD 158.6 million, at year-end 2027.
The Asia-Pacific region, which includes China, Japan, India, Australia and South Korea, offers a large market for bilirubin blood tests. This is due to the fact that the government of these countries is investing a large part of its resources in the development of a strong medical infrastructure. The market in these regions will grow at a CAGR of 6.45%. Only China had a market share of 34.10% in 2015.
The rest of the world, which includes parts of the Middle East and Africa, is experiencing steady but slow growth due to limited government resources and a lack of public awareness.
competitive scenario
The list of key players involved in the analysis of the global Bilirubin Blood Test market is as follows:
- Royal Philips NV (North Holland)
- Beckman Coulter, Inc. (EE. UU.)
- Thermo Fisher Scientific Inc. (EE. UU.)
- Randox Laboratories Ltd. (UK)
- Hoffmann-La Roche AG (Switzerland)
- Drägerwerk AG & Co. KGaA (Germany)
- Geneva (Italy)
- Advanced Instruments (USA)
- Reichert, Inc. (USA)
- Instrumentation Laboratory (USA).
- AVI Healthcare SA Limited.
The companies mentioned above work on testing and creating new equipment and techniques in the field of blood bilirubin testing. They come together in joint ventures, mergers and acquisitions, launching new devices. Its main objective is to offer devices that are economical, without complications in operations and that provide concrete results.
Report scope:
Report attribute/metric | Details |
---|---|
market size | US$ 1,853.2 million |
CAGR | 5,44% |
what base | 2019 |
forecast period | 2027 |
historical information | 2018 |
forecast units | Value (millions of USD) |
report coverage | Revenue forecasting, competitive landscape, growth drivers and trends |
segments covered | Type of test, type of product, applications and end user |
Covered geographies | North America, Europe, Asia Pacific and Rest of the World (RoW) |
main suppliers | Koninklijke Philips N.V. (North Holland), Beckman Coulter, Inc. (USA), Thermo Fisher Scientific Inc. (USA), Randox Laboratories Ltd. (UK), Hoffmann-La Roche AG (Switzerland), Drägerwerk AG & Co. KGaA (Germany), Ginevry (Italy), Advanced Instruments (USA), Reichert, Inc.; (USA), Instrumentation Laboratory (USA), AVI Healthcare Pvt. Limited. |
Main market opportunities | Developing countries can become potential markets for advanced bilirubin blood test devices |
Main market drivers | |
Frequently Asked Questions (FAQ):
What would be the projected CAGR of the Bilirubin Blood Test Market for the Forecast Period of 2020-2027?
The projected CAGR over the forecast period would be 5.44%.
What is the projected market valuation through 2027?
The market valuation of the bilirubin blood test would reach $1,853.2 million.
What was the total serum bilirubin market share in 2027?
The total market share of serum bilirubin was 47.37%.
Discuss the applications involved in the Bilirubin Blood Test market report.
Applications involve pediatric/infant and adult.
Mention the end users discussed in the Bilirubin Blood Test market report.
The report includes hospitals, home health care and pediatric clinics for discussion.